Hospital Profile
Name | Verde Valley Medical Center |
---|
Type | Acute Care Hospital |
---|
Location | 269 South Candy Lane, Cottonwood, Arizona |
---|
Ownership | Voluntary non-profit - Private |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 030007 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Verde Valley Medical Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1346291648 |
Organization Name | VERDE VALLEY MEDICAL CENTER |
Address | 269 S Candy Ln, Cottonwood, AZ 86326 |
Hospital Type | General Acute Care Hospital |
Phone Number | 928-773-2546 |
News Archive
Research reveals high level of bullying in midwifery
Midwifery culture must change to eradicate bullying at all levels of the profession - according to University of Ulster nursing experts who have just completed a five-year study of the issue.
Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics
Sirna Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Sirna U.S. Patent No. 6,989,442 for the chemical synthesis and manufacturing of ribonucleic acids (RNA).
EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
Eating a low energy density diet can offset influence of obesity gene
Children who carry a gene strongly associated with obesity could offset its effect by eating a low energy density diet, according to new research from UCL (University College London) and the University of Bristol published in PLoS ONE.
Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients
Regeneron Pharmaceuticals, Inc. and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology.
Read more Medical News
› Verified 1 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Research reveals high level of bullying in midwifery
Midwifery culture must change to eradicate bullying at all levels of the profession - according to University of Ulster nursing experts who have just completed a five-year study of the issue.
Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics
Sirna Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Sirna U.S. Patent No. 6,989,442 for the chemical synthesis and manufacturing of ribonucleic acids (RNA).
EZ-2 Series evaporator designed to suit solvent removal needs of most laboratories
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
Eating a low energy density diet can offset influence of obesity gene
Children who carry a gene strongly associated with obesity could offset its effect by eating a low energy density diet, according to new research from UCL (University College London) and the University of Bristol published in PLoS ONE.
Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients
Regeneron Pharmaceuticals, Inc. and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology.
Read more News
› Verified 1 days ago